Cytokine storm

Cited by (1,002)

Items 101–200 of 1,002

1. Blood omega-3 fatty acids and death from COVID-19: A pilot study
   Asher, Arash, Tintle, Nathan L., Myers, Michael, Lockshon, Laura, Bacareza, Heribert, Harris, William S. · 2021 · Prostaglandins, Leukotrienes and Essential Fatty Acids
2. CXCR6 is required for antitumor efficacy of intratumoral CD8 + T cell
   Binglin Wang, Yi Wang, Xiaofan Sun, Guoliang Deng, Wei Huang, Xingxin Wu, Yanghong Gu, Zhigang Tian, Zhimin Fan, Qiang Xu et al. · 2021 · Journal for ImmunoTherapy of Cancer
3. Proinflammatory cytokines levels in sepsis and healthy volunteers, and tumor necrosis factor-alpha associated sepsis mortality: A systematic review and meta-analysis
   Amal A. Gharamti, Omar Samara, Anthony Monzon, Gabrielle E Montalbano, Sias J. Scherger, Kristen DeSanto, Daniel B. Chastain, Stefan Sillau, José Gilberto Montoya, Carlos Franco‐Paredes et al. · 2022 · Cytokine
4. Interleukin-1 and the NLRP3 inflammasome in COVID-19: Pathogenetic and therapeutic implications
   Nicola Potere, Marco Giuseppe Del Buono, Roberto Caricchio, Paul C Cremer, Alessandra Vecchié, Ettore Porreca, Daniela Dalla Gasperina, Francesco Dentali, Antonio Abbate, Aldo Bonaventura · 2022 · EBioMedicine
5. Interleukin-6 receptor blockade in patients with COVID-19: placing clinical trials into context
   Federico Angriman, Bruno Leonel Ferreyro, Lisa D. Burry, Eddy Fan, Niall D. Ferguson, Shahid Husain, Shaf H Keshavjee, Enrico Lupia, Laveena Munshi, Samuele Renzi et al. · 2021 · The Lancet Respiratory Medicine
6. COVID-19 in immunocompromised populations: implications for prognosis and repurposing of immunotherapies
   Jason D. Goldman, Philip Cameron Robinson, Thomas S. Uldrick, Per T Ljungman · 2021 · Journal for ImmunoTherapy of Cancer
7. Safety, pharmacokinetics, and pharmacodynamics of LBP-EC01, a CRISPR-Cas3-enhanced bacteriophage cocktail, in uncomplicated urinary tract infections due to Escherichia coli (ELIMINATE): the randomised, open-label, first part of a two-part phase 2 trial
   Paul Kim, Ana Maria Sanchez, Taylor J.R. Penke, Hannah H. Tuson, J. Kime, Robert W. McKee, William L. Slone, Nicholas R. Conley, Lana J. McMillan, Cameron J. Prybol et al. · 2024 · The Lancet Infectious Diseases
8. Non-immunotherapy application of LNP-mRNA: Maximizing efficacy and safety
   Vlatkovic, Irena · 2021 · Biomedicines
9. Systemic adverse effects and toxicities associated with immunotherapy: A review
   Asim Kichloo, Michael Stanley Albosta, Dushyant Singh Dahiya, Jean Claude Guidi, Michael M. Aljadah, Jagmeet Singh, Hafeez Shaka, Farah Wani, Akshay Kumar, Manidhar Reddy Lekkala · 2021 · World Journal of Clinical Oncology
10. The triumvirate of NF-κB, inflammation and cytokine storm in COVID-19
    Ali Attiq, Lui Jin Yao, Sheryar Afzal, Mansoor Ali Khan · 2021 · International Immunopharmacology
11. Muscle strength and muscle mass as predictors of hospital length of stay in patients with moderate to severe COVID‐19: a prospective observational study
    Saulo dos Santos Gil, Wilson Jacob Filho, Samuel Katsuyuki Shinjo, Eduardo Ferriolli, Alexandre Leopold Busse, Thiago Junqueira Avelino‐Silva, Igor Longobardi, Gersiel Nascimento de Oliveira Júnior, Paul Alan Swinton, Bruno Gualano et al. · 2021 · Journal of Cachexia Sarcopenia and Muscle
12. A pairwise cytokine code explains the organism-wide response to sepsis
    Michihiro Takahama, Ashwini Patil, Katherine Johnson, Denis Cipurko, Yoshimi Miki, Yoshitaka Taketomi, Peter S. Carbonetto, Madison Plaster, Gabriella Richey, Surya Pandey et al. · 2024 · Nature Immunology
13. Magnesium in Infectious Diseases in Older People
    Ligia Juliana Dominguez, Nicola Veronese, Fernando Guerrero‐Romero, Mario Barbagallo · 2021 · Nutrients
14. Group IIA secreted phospholipase A2 is associated with the pathobiology leading to COVID-19 mortality
    Justin M. Snider, Jeehyun Karen You, Xia Wang, Ashley J. Snider, Brian Hallmark, Manja M. Zec, Michael C. Seeds, Susan Sergeant, Laurel M. Johnstone, Qiuming Wang et al. · 2021 · Journal of Clinical Investigation
15. A pH-/Enzyme-Responsive Nanoparticle Selectively Targets Endosomal Toll-like Receptors to Potentiate Robust Cancer Vaccination
    Heming Xia, Mengmeng Qin, Zenghui Wang, Yaoqi Wang, Binlong Chen, Fangjie Wan, Mingmei Tang, Xingquan Pan, Ye Yang, Jianxiong Liu et al. · 2022 · Nano Letters
16. Exploring immune-related pathogenesis in lung injury: Providing new insights Into ALI/ARDS
    Jiajing Zheng, Ying Li, Xianbin Kong, Jinhe Guo · 2024 · Biomedicine & Pharmacotherapy
17. COVID-19 Vasculopathy: Mounting Evidence for an Indirect Mechanism of Endothelial Injury
    Roberto F. Nicosia, Giovanni Ligresti, Nunzia Caporarello, Shreeram Akilesh, Doménico Ribatti · 2021 · American Journal Of Pathology
18. PD-L1 Dysregulation in COVID-19 Patients
    Francesco Sabbatino, Valeria Conti, Gianluigi Franci, Carmine Sellitto, Valentina Manzo, Pasquale Pagliano, Emanuela De Bellis, Alfonso Masullo, Francesco Antonio Salzano, Alessandro Caputo et al. · 2021 · Frontiers in Immunology
19. Renal Replacement Techniques in Septic Shock
    Tapio Hellman, Panu Uusalo, Mikko J. Järvisalo · 2021 · International Journal of Molecular Sciences
20. Single-cell RNA analysis reveals the potential risk of organ-specific cell types vulnerable to SARS-CoV-2 infections
    Zilong Zhang, Feifei Cui, Chen Cao, Qingsuo Wang, Quan Zou · 2021 · Computers in Biology and Medicine
21. The Roles of Neutrophils in Cytokine Storms
    Lily Chan, Negar Karimi, Solmaz Morovati, Kasra Alizadeh, Julia E. Kakish, Sierra Vanderkamp, Fatemeh Fazel, Christina Napoleoni, Kimia Alizadeh, Yeganeh Mehrani et al. · 2021 · Viruses
22. DrugCentral 2023 extends human clinical data and integrates veterinary drugs
    Avram, Sorin, Wilson, Thomas B, Curpan, Ramona, Halip, Liliana, Borota, Ana, Bora, Alina, Bologa, Cristian G, Holmes, Jayme, Knockel, Jeffrey, Yang, Jeremy J et al. · 2023 · Nucleic Acids Research
23. Pathogenesis and Treatment of Cytokine Storm Induced by Infectious Diseases
    Xidian Tang, Tian-Tian Ji, Jia-Rui Dong, Hao Feng, Feng-Qiang Chen, Xi Chen, Huiying Zhao, Dekun Chen, Wentao Ma · 2021 · International Journal of Molecular Sciences
24. From Infection to Death: An Overview of the Pathogenesis of Visceral Leishmaniasis
    Carlos Henrique Nery Costa, Kwang Poo Chang, Dorcas Lamounier Costa, Francisco Valmor Macedo Cunha · 2023 · Pathogens
25. Cytokine release syndrome in a patient with colorectal cancer after vaccination with BNT162b2
    Lewis Au, Annika Fendler, Scott Thomas Colville Shepherd, Karolina Rzeniewicz, Maddalena Cerrone, Fiona Byrne, Eleanor Carlyle, Kim Edmonds, Lyra Del Rosario, John C Shon et al. · 2021 · Nature Medicine
26. Combined angiogenesis and PD-1 inhibition for immunomodulatory TNBC: concept exploration and biomarker analysis in the FUTURE-C-Plus trial
    Song‐Yang Wu, Ying Xu, Li Chen, Lei Fan, Xiao-Yan Ma, Shen Zhao, Xiao-Qing Song, Xin Hu, Wen-Tao Yang, Wen-Jun Chai et al. · 2022 · Molecular Cancer
27. Identification of Three Different Phenotypes in Anti–Melanoma Differentiation–Associated Gene 5 Antibody–Positive Dermatomyositis Patients: Implications for Prediction of Rapidly Progressive Interstitial Lung Disease
    Lingxiao Xu, Hanxiao You, Lei Wang, Chengyin Lv, Fenghong Yuan, Ju Li, Min Wu, Zhanyun Da, Hua Wei, Wei Yan et al. · 2022 · Arthritis & Rheumatology
28. PANoptosis in Viral Infection: The Missing Puzzle Piece in the Cell Death Field
    Lam Nhat Nguyen, Thirumala‐Devi Kanneganti · 2021 · Journal of Molecular Biology
29. Role of SARS-CoV-2-induced cytokine storm in multi-organ failure: Molecular pathways and potential therapeutic options
    Yasaman Nazerian, Mobina Ghasemi, Younes Yassaghi, Amirhossein Nazerian, Seyed Mahmoud Hashemi · 2022 · International Immunopharmacology
30. Blood Interferon-α Levels and Severity, Outcomes, and Inflammatory Profiles in Hospitalized COVID-19 Patients
    Marco Contoli, Alberto A. Papi, L. Tomassetti, Paola Rizzo, Francesco Vieceli Dalla Sega, Francesca Fortini, Francesca Torsani, Luca Morandi, Luca Ronzoni, Ottavio Zucchetti et al. · 2021 · Frontiers in Immunology
31. Pathophysiology of chikungunya virus infection associated with fatal outcomes
    William Marciel de Souza, Marcílio Jorge Fumagalli, Shirlene Telmos Silva de Lima, Pierina Lorencini Parise, Deyse Cristina Madruga Carvalho, Cristian Hernandez, Ronaldo de Jesus, Jeany Delafiori, Darlan da Silva Cândido, Victor Corasolla Carregari et al. · 2024 · Cell Host & Microbe
32. Association of vitamin D status with COVID-19 and its severity
    Jae Hyun Bae, Hun Jee Choe, Michael F. Holick, Soo Kyung Lim · 2022 · Reviews in Endocrine and Metabolic Disorders
33. Is severe COVID-19 a cytokine storm syndrome: a hyperinflammatory debate
    Puja Mehta, David C. Fajgenbaum · 2021 · Current Opinion in Rheumatology
34. COVID-19: Inflammatory Profile
    Yuhang Wang, Stanley M. Perlman · 2021 · Annual Review of Medicine
35. Signaling pathways in the regulation of cytokine release syndrome in human diseases and intervention therapy
    Xia Li, Mi Shao, Xiangjun Zeng, Pengxu Qian, He Huang · 2021 · Signal Transduction and Targeted Therapy
36. Aging, inflammaging and immunosenescence as risk factors of severe COVID-19
    Anteneh Mehari Tizazu, Hylemariam Mihiretie Mengist, Gebreselassie Demeke · 2022 · Immunity & Ageing
37. JAK inhibitors: Ten years after
    Francesca Romana Spinelli, Françoise Meylan, John J. O’Shea, Massimo Gadina · 2021 · European Journal of Immunology
38. Recent advances in understanding spleen tyrosine kinase (SYK) in human biology and disease, with a focus on fostamatinib
    Nichola Cooper, Waleed Ghanima, Quentin A. Hill, Phillip L.R. Nicolson, Vadim V. Markovtsov, Craig M. Kessler · 2022 · Platelets
39. The role of caspase-8 in inflammatory signalling and pyroptotic cell death
    Jiyi Pang, James Edward Vince · 2023 · Seminars in Immunology
40. Races of small molecule clinical trials for the treatment of COVID‐19: An up‐to‐date comprehensive review
    Suwen Hu, Songwei Jiang, Qi Xiang, Renren Bai, Xiang‐Yang Ye, Tian Xie · 2021 · Drug Development Research
41. TIM3+ TRBV11-2 T cells and IFNγ signature in patrolling monocytes and CD16+ NK cells delineate MIS-C
    Levi Hoste, Lisa Roels, Leslie Naesens, Victor Bosteels, Stijn Vanhee, Sam Dupont, Cédric Bosteels, Robin Browaeys, Niels Vandamme, Kevin Verstaen et al. · 2021 · The Journal of Experimental Medicine
42. COVID ‐19 and the peripheral nervous system. A 2‐year review from the pandemic to the vaccine era
    Arens Taga, Giuseppe Lauria · 2022 · Journal of the Peripheral Nervous System
43. Classification, function, and advances in tsRNA in non-neoplastic diseases
    Liou Zhang, Jie Liu, Yang Hou · 2023 · Cell Death and Disease
44. Traumatic inflammatory response: pathophysiological role and clinical value of cytokines
    Rui Li, Jing Jing Ye, Lebin Gan, Mengwei Zhang, Diya Sun, Yongzheng Li, Tianbing Wang, Panpan Chang · 2023 · European Journal of Trauma and Emergency Surgery
45. Reactions and adverse events induced by T-cell engagers as anti-cancer immunotherapies, a comprehensive review
    Arthur Géraud, Thomas Hueso, Ariane Laparra, Naïke Bigé, Kaïssa Ouali, Cécile A. Cauquil, Annabelle Stoclin, François‐Xavier Danlos, Antoine Hollebecque, Vincent Ribrag et al. · 2024 · European Journal of Cancer
46. Brain dysfunction in COVID‐19 and CAR‐T therapy: cytokine storm‐associated encephalopathy
    Umberto Pensato, Lorenzo Muccioli, Ilaria Cani, Damir Janigro, Pier Luigi Zinzani, Maria Guarino, Pietro Cortelli, Francesca Bisulli · 2021 · Annals of Clinical and Translational Neurology
47. Serum Complement C3 and C4 and COVID-19 Severity and Mortality: A Systematic Review and Meta-Analysis With Meta-Regression
    Angelo Zinellu, Arduino Aleksander Mangoni · 2021 · Frontiers in Immunology
48. C-Reactive Protein Velocity (CRPv) as a New Biomarker for the Early Detection of Acute Infection/Inflammation
    Tal Levinson, Asaf Wasserman · 2022 · International Journal of Molecular Sciences
49. Overview of the immunological mechanism underlying severe fever with thrombocytopenia syndrome (Review)
    Tao Yang, Huaying Huang, Longfeng Jiang, Jun Li · 2022 · International Journal of Molecular Medicine
50. Impact of aging on immunity in the context of COVID-19, HIV, and tuberculosis
    Alba Grifoni, Tonino Alonzi, Galit Alter, Douglas McClain Noonan, ALAN L. LANDAY, Adriana Albini, Delia Goletti · 2023 · Frontiers in Immunology
51. SARS-CoV-2-triggered mast cell rapid degranulation induces alveolar epithelial inflammation and lung injury
    Mengli Wu, Feng‐Liang Liu, Jing Sun, Xin Li, Xiao-Yan He, Hong‐Yi Zheng, Rongjuan Pei, Hao Sun, Yan-Heng Zhou, Qihong Yan et al. · 2021 · Signal Transduction and Targeted Therapy
52. Phenotypic and Transcriptional Changes of Pulmonary Immune Responses in Dogs Following Canine Distemper Virus Infection
    Elisa Chludzinski, Johanna Klemens, Małgorzata Ciurkiewicz, Robert Geffers, Pauline Pöpperl, Melanie Stoff, Dai‐Lun Shin, Georg Herrler, Andreas Beineke · 2022 · International Journal of Molecular Sciences
53. COVID-19-associated Aspergillus tracheobronchitis: the interplay between viral tropism, host defence, and fungal invasion
    Frank L. van de Veerdonk, Roger J. M. Brüggemann, Shoko Vos, Gert D. Hertogh, Joost Wauters, Monique H E Reijers, Mihai Gheorghe Netea, Jeroen A. Schouten, Paul E. Verweij · 2021 · The Lancet Respiratory Medicine
54. Leukemic Stem Cells: From Leukemic Niche Biology to Treatment Opportunities
    Tony Marchand, Sandra Pinho · 2021 · Frontiers in Immunology
55. Recent advances and evolving concepts in Still’s disease
    Piero Ruscitti, Luca Cantarini, Peter Andrija Nigrovic, Dennis McGonagle, Roberto Giacomelli · 2024 · Nature Reviews Rheumatology
56. Rapid electrochemical dual-target biosensor composed of an Aptamer/MXene hybrid on Au microgap electrodes for cytokines detection
    Seungwoo Noh, Hoseok Lee, Jinmyeong Kim, Hongje Jang, Jeongyun An, Chul-Whan Park, Min‐Ho Lee, Taek Lee · 2022 · Biosensors and Bioelectronics
57. Biofilm exopolysaccharides alter sensory-neuron-mediated sickness during lung infection
    Elise Granton, Luke Brown, Manon Defaye, Parisa Moazen, Henrik Almblad, Trevor E. Randall, Jacquelyn D. Rich, Andrew Geppert, Nasser S. Abdullah, Mortaza Fatehi Hassanabad et al. · 2024 · Cell
58. Exploring CAR-T Cell Therapy Side Effects: Mechanisms and Management Strategies
    Yugu Zhang, Diyuan Qin, Arthur Shou, Yanbin Liu, Yongsheng Wang, Lingyun Zhou · 2023 · Journal of Clinical Medicine
59. Proteomic profiling of MIS-C patients indicates heterogeneity relating to interferon gamma dysregulation and vascular endothelial dysfunction
    Caroline J. Diorio, Rawan Shraim, Laura A. Vella, Josephine Ruth Giles, Amy E. Baxter, Derek A. Oldridge, Scott Canna, Sarah Emily Henrickson, Kevin Owen McNerney, Fran Balamuth et al. · 2021 · Nature Communications
60. Effect of Systemic Inflammation in the CNS: A Silent History of Neuronal Damage
    Mara Verónica Millán Solano, Citlaltépetl Salinas Lara, Carlos Sánchez-Garibay, Luis Oskar Soto-Rojas, Itzel Escobedo-Ávila, Martha Lilia Tena‐Suck, Rocı́o Ortiz-Butrón, José Alberto Choreño-Parra, José Pablo Romero‐López, María Estela Meléndez-Camargo · 2023 · International Journal of Molecular Sciences
61. The roles of critical pro‐inflammatory cytokines in the drive of cytokine storm during SARS‐CoV‐2 infection
    Muhammad Suhaib Qudus, Mingfu Tian, Summan Sirajuddin, Siyu Liu, Uzair Afaq, Muneeba Wali, Jinbiao Liu, Pan Pan, Zhen Luo, Qiwei Zhang et al. · 2023 · Journal of Medical Virology
62. Dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status in the USA: a prospective cohort study
    Xianming Zhu, Kelly A. Gebo, Alison G. Abraham, Feben Habtehyimer, Eshan U. Patel, Oliver B Laeyendecker, Thomas J. Gniadek, Reinaldo E. Fernández, Owen R. Baker, Malathi Ram et al. · 2023 · The Lancet Microbe
63. Infectious complications of CAR T-cell therapy across novel antigen targets in the first 30 days
    Mikkilineni, Lekha, Yates, Bonnie, Steinberg, Seth M., Shahani, Shilpa A., Molina, John C., Palmore, Tara, Lee, Daniel W., Kaplan, Rosandra N., Mackall, Crystal L., Fry, Terry J. et al. · 2021 · Blood Advances
64. Endothelial dysfunction contributes to severe COVID-19 in combination with dysregulated lymphocyte responses and cytokine networks
    Louisa Ruhl, Isabell Pink, Jenny F. Kühne, Kerstin Beushausen, Jana Keil, Stella Christoph, Andrea Sauer, Lennart Boblitz, Julius Schmidt, Sascha David et al. · 2021 · Signal Transduction and Targeted Therapy
65. COVID-19 and Acute Kidney Injury
    James Hilton, Naomi Boyer, Mitra K. Nadim, Lui G. Forni, John A. Kellum · 2022 · Critical Care Clinics
66. Cannabinoids Alleviate the LPS-Induced Cytokine Storm via Attenuating NLRP3 Inflammasome Signaling and TYK2-Mediated STAT3 Signaling Pathways In Vitro
    Santosh V. Suryavanshi, Mariia Zaiachuk, Nazar Pryimak, Igor Kovalchuk, Olga Kovalchuk · 2022 · Cells
67. T-cell-engaging antibodies for the treatment of solid tumors: challenges and opportunities
    Patrick A. Baeuerle, Holger Wesche · 2022 · Current Opinion in Oncology
68. New genetic and epigenetic insights into the chemokine system: the latest discoveries aiding progression toward precision medicine
    Hanli Xu, Shuye Lin, Ziyun Zhou, Duoduo Li, Xiting Zhang, Muhan Yu, Ruoyi Zhao, Yiheng Wang, Junru Qian, Xinyi Li et al. · 2023 · Cellular and Molecular Immunology
69. Synthetic Gene Circuits for Regulation of Next‐Generation Cell‐Based Therapeutics
    Ana P. Teixeira, Martin Fussenegger · 2023 · Advanced Science
70. Functional pathophysiology of SARS-CoV-2-induced acute lung injury and clinical implications
    Nader M. Habashi, Luigi Camporota, Louis A. Gatto, Gary F. Nieman · 2021 · Journal of Applied Physiology
71. Understanding the Co-Epidemic of Obesity and COVID-19: Current Evidence, Comparison with Previous Epidemics, Mechanisms, and Preventive and Therapeutic Perspectives
    Μaria Dalamaga, Gerasimos Socrates Christodoulatos, Ιrene Karampela, Natalia G. Vallianou, Caroline Margaret Apovian · 2021 · Current Obesity Reports
72. The pathophysiology of sepsis—2021 update: Part 1, immunology and coagulopathy leading to endothelial injury
    Judith Jacobi · 2021 · American Journal of Health-System Pharmacy
73. Anti-viral triterpenes: a review
    Priya Darshani, Shreya Sen Sarma, Amit Kumar Srivastava, Rinku Baishya, Deepak Kumar · 2022 · Phytochemistry Reviews
74. Lymphoma-associated hemophagocytic lymphohistiocytosis (LA-HLH): a scoping review unveils clinical and diagnostic patterns of a lymphoma subgroup with poor prognosis
    Johanna Knauft, Thomas Schenk, Thomas Ernst, Ulf Schnetzke, Andreas Hochhaus, Paul Graf La Rosée, Sebastian Birndt · 2024 · Leukemia
75. EGCG, a Green Tea Catechin, as a Potential Therapeutic Agent for Symptomatic and Asymptomatic SARS-CoV-2 Infection
    Mukesh Chourasia, Purushotham Reddy Koppula, Aruna Battu, Madhu Micheal Ouseph, Anil Singh · 2021 · Molecules
76. Neurotropism of SARS-CoV-2 and neurological diseases of the central nervous system in COVID-19 patients
    Shobi Veleri · 2021 · Experimental Brain Research
77. Detailed overview of incidence and management of cytokine release syndrome observed with teclistamab in the MajesTEC‐1 study of patients with relapsed/refractory multiple myeloma
    Thomas G Martin, María‐Victoria Mateos, Ajay K. Nooka, Arnob Banerjee, Rachel Kobos, Lixia Pei, Ming Qi, Raluca I. Verona, Margaret Doyle, Jennifer Smit et al. · 2023 · Cancer
78. Association Between COVID-19 Pregnant Women Symptoms Severity and Placental Morphologic Features
    Patrícia Zadorosnei Rebutini, Aline Cristina Zanchettin, Emanuele Therezinha Schueda Stonoga, Daniele Margarita Marani Prá, André Luiz Parmegiani de Oliveira, Felipe da Silva Dezidério, Aline Simoneti Fonseca, Júlio César Honório D’Agostini, Elisa Carolina Hlatchuk, Isabella Naomi Furuie et al. · 2021 · Frontiers in Immunology
79. Progress in preclinical studies of macrophage autophagy in the regulation of ALI/ARDS
    Chang Liu, Kun Xiao, Lixin Xie · 2022 · Frontiers in Immunology
80. Tobacco product use and the risks of SARS-CoV-2 infection and COVID-19: current understanding and recommendations for future research
    Neal L. Benowitz, Maciej Lukasz Goniewicz, Bonnie L. Halpern‐Felsher, Suchitra Krishnan‐Sarin, Pamela May Ling, Richard J. O’Connor, Mary Ann Pentz, Rose Marie Robertson, Aruni Bhatnagar · 2022 · The Lancet Respiratory Medicine
81. Manganese molybdate nanodots with dual amplification of STING activation for “cycle” treatment of metalloimmunotherapy
    Huali Lei, Quguang Li, Guangqiang Li, Tianyi Wang, Xinjing Lv, Zifan Pei, Xiang Gao, Nailin Yang, Fei Gong, Yuqi Yang et al. · 2023 · Bioactive Materials
82. Mechanisms of endothelial activation, hypercoagulation and thrombosis in COVID-19: a link with diabetes mellitus
    Inés Valencia, Jairo Lumpuy‐Castillo, Giselle Santos Magalhães, Carlos F. Sánchez‐Ferrer, Óscar Lorenzo, Concepción Peiró · 2024 · Cardiovascular Diabetology
83. RETRACTED: Interleukin-6 in SARS-CoV-2 induced disease: Interactions and therapeutic applications
    Jamal Majidpoor, Keywan Mortezaee · 2021 · Biomedicine & Pharmacotherapy · Retracted
84. CytoSorb Rescue for COVID-19 Patients With Vasoplegic Shock and Multiple Organ Failure: A Prospective, Open-Label, Randomized Controlled Pilot Study*
    Helena Stockmann, Philipp Thelen, Fabian Stroben, Mareen Pigorsch, Theresa Keller, Alexander Krannich, Claudia Spies, Sascha Treskatsch, Michele Ocken, Julius Valentin Kunz et al. · 2022 · Critical Care Medicine
85. Integrating single-cell sequencing data with GWAS summary statistics reveals CD16+monocytes and memory CD8+T cells involved in severe COVID-19
    Yunlong Ma, Fei Qiu, Chunyu Deng, Jingjing Li, Yukuan Huang, Zeyi Wu, Yijun Zhou, Yaru Zhang, Yichun Xiong, Yinghao Yao et al. · 2022 · Genome Medicine
86. TLRs: Innate Immune Sentries against SARS-CoV-2 Infection
    Stefania Mantovani, Barbara Oliviero, Stefania Varchetta, Alessandra Renieri, Mario Umberto Mondelli · 2023 · International Journal of Molecular Sciences
87. Endothelial dysfunction contributes to severe COVID-19 in combination with dysregulated lymphocyte responses and cytokine networks
    Louisa Ruhl, Isabell Pink, Jenny F. Kühne, Kerstin Beushausen, Jana Keil, Stella Christoph, Andrea Sauer, Lennart Boblitz, Julius J. Schmidt, Sascha David et al. · 2021 · Zurich Open Repository and Archive (University of Zurich)
88. Dysregulated Interferon Response and Immune Hyperactivation in Severe COVID-19: Targeting STATs as a Novel Therapeutic Strategy
    Mahdi Eskandarian Boroujeni, Agata Sekrecka, Aleksandra Antonczyk, Sanaz Hassani, Michał Sekrecki, Hanna Nowicka, Natalia Łopacinska, Arta Olya, Katarzyna Kluzek, Joanna Wesoły et al. · 2022 · Frontiers in Immunology
89. Roles of systemic inflammatory and metabolic responses in the pathophysiology of acute-on-chronic liver failure
    Joan Clària, Vicente Arroyo, Richard Moreau · 2023 · JHEP Reports
90. Status epilepticus and COVID-19: A systematic review
    Fedele Dono, Bruna Nucera, Jacopo Lanzone, Giacomo Evangelista, Fabrizio Rinaldi, Rino Speranza, Serena Troisi, Lorenzo Tinti, Mirella Russo, Martina Di Pietro et al. · 2021 · Epilepsy & Behavior
91. Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19
    Hayder Mutter Al-Kuraishy, Ali Ismail Al-Gareeb, Gomaa Mostafa‐Hedeab, Keneth Iceland Kasozi, Gerald Zirintunda, Akhmed Aslam, Mamdouh A. Allahyani, Susan C. Welburn, Gaber El‐Saber Batiha · 2021 · Frontiers in Immunology
92. Viral Mimicry of Interleukin-17A by SARS-CoV-2 ORF8
    Xin Wu, Tian Xia, Woo-Jin Shin, Kwang-Min Yu, WooRam Jung, Alexandra Herrmann, Suan‐Sin Foo, Weiqiang Chen, Pengfei Zhang, Jong‐Soo Lee et al. · 2022 · mBio
93. A defective viral genome strategy elicits broad protective immunity against respiratory viruses
    Yinghong Xiao, Peter V. Lidsky, Yuta Shirogane, Ranen Aviner, Chien-Ting Wu, Weiyi Li, Weihao Zheng, Dale Talbot, Adam Catching, Gilad Doitsh et al. · 2021 · Cell
94. Safety and feasibility of stem cell boost as a salvage therapy for severe hematotoxicity after CD19 CAR T-cell therapy
    Kai Rejeski, Andreas Burchert, Gloria Iacoboni, Pierre Sesques, Lars R. Fransecky, Veit Bücklein, Corinna Trenker, Rafael Hernani, Ralph Naumann, Jonas Schäfer et al. · 2022 · Blood Advances
95. Mechanisms of sepsis-induced acute liver injury: a comprehensive review
    Yongjing Guo, Wanxu Guo, Huimin Chen, Jian Sun, Yongjie Yin · 2025 · Frontiers in Cellular and Infection Microbiology
96. Covid‐19 and Liver Injury: Role of Inflammatory Endotheliopathy, Platelet Dysfunction, and Thrombosis
    M. McConnell, Reiichiro Kondo, N. Kawaguchi, Y. Iwakiri · 2021 · Hepatology Communications
97. Role of PKM2-Mediated Immunometabolic Reprogramming on Development of Cytokine Storm
    Zhijun Liu, Yifei Le, Hang Chen, Ji Zhu, Dezhao Lu · 2021 · Frontiers in Immunology
98. The IL-1 cytokine family as custodians of barrier immunity
    Laura Matarazzo, Yasmina Hernandez-Santana, Patrick T. Walsh, Padraic G. Fallon · 2022 · Cytokine
99. Cytokine Responses to Adenovirus and Adenovirus Vectors
    Svetlana Atasheva, Dmitry M. Shayakhmetov · 2022 · Viruses
100. Circulating microRNA signatures associated with disease severity and outcome in COVID-19 patients
     Alessandra Giannella, Silvia Riccetti, Alessandro Sinigaglia, Chiara Piubelli, Elisa Razzaboni, Piero Di Battista, Matteo Agostini, Emanuela Dal Molin, Riccardo Manganelli, Federico Giovanni Gobbi et al. · 2022 · Frontiers in Immunology